Top Markets
Coin of the day
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
株式のランク #15061
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
株価
$4.66
時価総額
$43.92M
変化(1日)
-0.63%
変化(1年)
338.04%
FR
取引 Theranexus Société Anonyme (ALTHX)

カテゴリー

Theranexus Société Anonyme(ALTHX)のP/B比率
July 2026 時点のP/B比率 TTM: 23.01
Theranexus Société Anonyme の最新の財務報告および株価によると、現在のP/B比率(TTM)は 23.01 です。2023 年末時点でのP/B比率は 3.91 でした。
Theranexus Société Anonyme の P/B 比率の履歴(2015 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
2026 (TTM) 23.01 -872.06%
2024 -2.98 -176.13%
2023 3.91 140.89%
2022 1.62 -32.16%
2021 2.39 -67.52%
2020 7.37 537.01%
2019 1.16 -73.36%
2018 4.34 72.54%
2017 2.52 -98.37%
2016 154.33 1,766.00%
2015 8.27 0.00%
同業他社のP/B比率
企業 P/B比率 P/B比率の差
6.8826 -70.09%
DK
6.5189 -71.67%
US
2.0637 -91.03%
US
4.5808 -80.09%
BE
7.7629 -66.26%
NL